eFFECTOR Therapeutics Inc (STU:LWK)
€ 9.25 0 (0%) Market Cap: 29.23 Mil Enterprise Value: 31.69 Mil PE Ratio: 0 PB Ratio: 0.23 GF Score: 21/100

eFFECTOR Therapeutics Inc at Stifel Healthcare Conference Transcript

Nov 15, 2022 / 02:10PM GMT
Release Date Price: €12.05 (-7.31%)
Ben Burnett
Stifel Financial Corp. - Analyst

I think we'll go ahead and get started for the next session. Ben Burnett from Stifel. Pleased to have eFFECTOR Therapeutics with us today for a fireside chat. We have CFO, Mike Byrnes here; and CMO, Dr. Doug Warner. (technical difficulty) So we'll do a fireside chat for this one. (Conference Instructions)

But I think maybe just to kick it off, could you guys just maybe provide a brief overview of eFFECTOR, highlight near-term events that we should be focused on?

Mike Byrnes
eFFECTOR Therapeutics, Inc. - CFO

Sure. Absolutely. Thanks, Ben, and thanks to the Stifel team for hosting this conference again in person, which is great, back in New York City. So eFFECTOR was formed about 10 years ago, really to have a profound effect on blocking translation and profound effect in cancer.

So what we focused on specifically was one of the most mutated pathways in cancer, the RAS PI3K pathway. And instead of focusing on sort of the top end of that pathway, we focused on the bottom, which is the eIF4F complex

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot